Nasopharyngeal carcinoma pathophysiology: Difference between revisions
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 42: | Line 42: | ||
*EBER positive | *EBER positive | ||
*p16 negative<ref name="pmid9546345">{{cite journal |author=Gulley ML, Nicholls JM, Schneider BG, Amin MB, Ro JY, Geradts J |title=Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product |journal=Am. J. Pathol. |volume=152 |issue=4 |pages=865–9 |year=1998 |month=April |pmid=9546345 |pmc=1858242 |doi= |url=}}</ref> | *p16 negative<ref name="pmid9546345">{{cite journal |author=Gulley ML, Nicholls JM, Schneider BG, Amin MB, Ro JY, Geradts J |title=Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product |journal=Am. J. Pathol. |volume=152 |issue=4 |pages=865–9 |year=1998 |month=April |pmid=9546345 |pmc=1858242 |doi= |url=}}</ref> | ||
==Associated Conditions== | |||
Conditions associated with [disease name] include: | |||
*[Condition 1] | |||
*[Condition 2] | |||
*[Condition 3] | |||
==Gross Pathology== | |||
On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name]. | |||
==Microscopic Pathology== | |||
On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name]. | |||
==References== | ==References== | ||
Revision as of 18:13, 29 October 2019
|
Nasopharyngeal carcinoma Microchapters |
|
Differentiating Nasopharyngeal carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nasopharyngeal carcinoma pathophysiology On the Web |
|
American Roentgen Ray Society Images of Nasopharyngeal carcinoma pathophysiology |
|
Risk calculators and risk factors for Nasopharyngeal carcinoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]
Overview
On microscopic histopathological analysis, abundant dense eosinophilic cytoplasm and prominent lymphoid component are characteristic findings of nasopharyngeal carcinoma.
Pathophysiology
Genetics
Genes involved in the pathogenesis of nasopharyngeal carcinoma include:
Pathology
Gross Pathology
- Nasal cavity involvement - common in early disease[1]
The tumor arises from epithelial cells on the surface of the nasopharynx.
Microscopic Pathology
Features:[2]
- Prominent lymphoid component (Lymphoepithelioma) - key feature
- Features of squamous cell carcinoma:
Nasopharyngeal carcinoma may be classified according to microscopic features into 3 subtypes:[3]
- Well-differentiated (keratinizing type)
- Moderately-differentiated (nonkeratinizing type)
- Undifferentiated (most strongly associated with Epstein-Barr virus infection)
-
Undifferentiated nasopharyngeal carcinoma - low power -
Undifferentiated nasopharyngeal carcinoma - med. power -
Undifferentiated nasopharyngeal carcinoma - high power
Immunohistochemistry
Immunohistochemistry stains for nasopharyngeal carcinoma include:
- EBER positive
- p16 negative[4]
Associated Conditions
Conditions associated with [disease name] include:
- [Condition 1]
- [Condition 2]
- [Condition 3]
Gross Pathology
On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Microscopic Pathology
On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
References
- ↑ Abdel Khalek Abdel Razek, A.; King, A. (2012). "MRI and CT of nasopharyngeal carcinoma". AJR Am J Roentgenol. 198 (1): 11–8. doi:10.2214/AJR.11.6954. PMID 22194474. Unknown parameter
|month=ignored (help) - ↑ Nasopharyngeal carcinoma http://librepathology.org/wiki/index.php/Nasopharyngeal_carcinoma
- ↑ Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor). Modern Surgical Pathology (2 Volume Set). London: W B Saunders. ISBN 0-7216-7253-1.
- ↑ Gulley ML, Nicholls JM, Schneider BG, Amin MB, Ro JY, Geradts J (1998). "Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product". Am. J. Pathol. 152 (4): 865–9. PMC 1858242. PMID 9546345. Unknown parameter
|month=ignored (help)